Stage IV Lymphoepithelioma of the Nasopharynx
specificStage IV includes: IVA: (T4, N0, M0); (T4, N1, M0); (T4, N2, M0); IVB (Any T, N3, M0); IVC (Any T, Any N, M1). T4: Nasopharyngeal cancer with intracranial extension and/or involvement of cranial nerves, hypopharynx, orbit, or with extension to the infratemporal fossa/masticator space. N0: No regional lymph node metastasis. N1: Nasopharyngeal cancer with unilateral metastasis in cervical lymph node(s), 6 cm or less in greatest dimension, above the supraclavicular fossa, and/or unilateral or bila
6
Centers
0
Active Trials
—
Cancer Funding
Top Centers for Stage IV Lymphoepithelioma of the Nasopharynx(6)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive | 58.3 |
| 2 | Fred Hutch Cancer CenterSeattle, WA NCI Comprehensive | 58.3 |
| 3 | Vanderbilt-Ingram Cancer CenterNashville, TN NCI Comprehensive | 58.3 |
| 4 | University of Illinois Cancer CenterChicago, IL | 58.3 |
| 5 | Fox Chase Cancer CenterPhiladelphia, PA NCI Comprehensive | 58.3 |
| 6 | Upstate Cancer CenterSyracuse, NY | 58.3 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →